肼基乙酸乙酯 | 637-80-9

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 肼基乙酸乙酯
• 英文名称: ethyl 2-hydrazinylacetate
• 英文别名: ethyl hydrazinoacetate；ethyl aminoglycinate hydrochloride；hydrazinoacetic acid ethyl ester
• CAS: 637-80-9
• 化学式: C₄H₁₀N₂O₂
• 分子量: 118.136
• InChiKey: GETVBTMFGVOGRW-UHFFFAOYSA-N

物化性质

• 熔点：
  152 °C
• 沸点：
  67 °C(Press: 1.5 Torr)
• 密度：
  1.068±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -0.7
• 重原子数：
  8
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  64.4
• 氢给体数：
  2
• 氢受体数：
  4

安全信息

• 海关编码：
  2928000090
• WGK Germany：
  3

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: Ethyl hydrazinoacetate, HCl
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: Ethyl hydrazinoacetate, HCl
CAS number: 637-80-9

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C4H10N2O2.ClH
Molecular weight: 154.6

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  肼基乙酸乙酯 在 亚硝酸 作用下， 生成 重氮乙酸乙酯
  参考文献：
  名称：

  Darapsky; Prabhakar, Chemische Berichte, 1912, vol. 45, p. 1665

  摘要：

  DOI：
• 作为产物：
  描述：

  重氮乙酸乙酯 生成 肼基乙酸乙酯
  参考文献：
  名称：

  氨基二酰肼-Umlaǵerungǵ。5. Mitteilung。尤伯杯死Hydrazoessigsäure † ‡ § ¶

  摘要：

  合成了羟基乙酸（7）和通过改变偶氮基或羧基的各种衍生物。7与金属离子形成络合物。在某些条件下，N-乙酰基-N'-缩水甘油基乙酸（17）被重排为N-（N-乙酰基-缩水甘油基）-肼基乙酸（18）。

  DOI：

  10.1002/hlca.19700530517

文献信息

• JNK INHIBITOR
  申请人：Takeda Chemical Industries, Ltd.

  公开号：EP1484320A1

  公开（公告）日：2004-12-08

  A JNK inhibitor containing a compound having an isoquinolinone skeleton or a salt thereof, such as a compound represented by the formula wherein ring A and ring B are each an optionally substituted benzene ring, X is -O-, -N=, -NR3- or -CHR3-, R2 is an acyl group, an optionally esterified or thioesterified carboxyl group, an optionally substituted carbamoyl group or an optionally substituted amino group and the like, a broken line shows a single bond or a double bond, and R1 is a hydrogen atom, an optionally substituted hydrocarbon group, an optionally substituted heterocyclic group and the like, and the like.

  一种含有异喹啉酮骨架或其盐的JNK抑制剂，例如由以下公式表示的化合物： 其中环A和环B分别是可选择取代的苯环，X是-O-，-N=，-NR3-或-CHR3-，R2是酰基，可选择酯化或硫酯化的羧基，可选择取代的氨基甲酰基或可选择取代的氨基等，虚线表示单键或双键，R1是氢原子，可选择取代的碳氢基团，可选择取代的杂环基团等。
• [5,6]HETEROCYCLIC COMPOUND
  申请人：Daiichi Sankyo Company, Limited

  公开号：EP2565185A1

  公开（公告）日：2013-03-06

  Abstract: An object of the present invention is to provide a novel low molecular weight compound exhibiting an osteogenesis-promoting action. This object is achieved by a compound having the general formula (I) or a pharmacologically acceptable salt thereof. In the general formula (I), R1 and R2 represent hydrogen atoms, and the like; R3 represents a hydrogen atom, and the like; X, Y, and Z represent nitrogen atoms, and the like; A represents a phenylene group, and the like; n represents 1 or 2, and the like; and V and W represent oxygen atoms, and the like.

  摘要：本发明的目的是提供一种表现出促进骨生成作用的新型低分子量化合物。该目的通过具有通式（I）或其药理学可接受的盐的化合物实现。在通式（I）中，R1和R2代表氢原子等；R3代表氢原子等；X、Y和Z代表氮原子等；A代表苯基等；n代表1或2等；V和W代表氧原子等。
• [EN] INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION<br/>[FR] INHIBITEURS DE LA RÉPLICATION DU VIRUS DE L'IMMUNODÉFICIENCE HUMAINE
  申请人：VIIV HEALTHCARE UK NO 5 LTD

  公开号：WO2021070054A1

  公开（公告）日：2021-04-15

  Compounds and pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth.

  化合物及其药用可接受的盐，以及用于治疗人类免疫缺陷病毒（HIV）感染的组合物和方法已列出。
• Oxime ether derivatives, a new class of nonsteroidal antiinflammatory compounds
  作者：Jan Van Dijk、Jan M. A. Zwagemakers

  DOI：10.1021/jm00219a018

  日期：1977.9

  pronounced antiinflammatory activity in the carrageenan-induced edema test in the rat. The activity was limited mainly to derivatives of p-haloacetophenone oxime and of p-halobenzaldehyde oxime. Nevertheless, the hydroxyethyl and carboxyalkyl groups may be converted into many derivatives with maintenance of activity. Some structure-activity relationships are in contrast to those of the well-known antiinflammatory

  在角叉菜胶诱发的大鼠水肿试验中，发现一系列新的芳香族肟的2-羟乙基和羧烷基醚具有明显的抗炎活性。活性主要限于对卤代苯乙酮肟和对卤代苯甲醛肟的衍生物。然而，在保持活性的情况下，羟乙基和羧烷基可被转化成许多衍生物。一些结构-活性关系与众所周知的抗炎性芳酸的相反。活性限于E立体异构体。选择2-（二甲基氨基）乙基（E）-[[（（对氯-α-甲基亚苄基）-氨基[氧]]乙酸盐（36，INN名称为Cloximate）的盐酸盐用于临床评估。第一结果与药理学前景相符。
• [EN] COMPOUNDS AND METHODS FOR PRODUCING A CONJUGATE<br/>[FR] COMPOSÉS ET PROCÉDÉS POUR PRODUIRE UN CONJUGUÉ
  申请人：REDWOOD BIOSCIENCE INC

  公开号：WO2014074218A1

  公开（公告）日：2014-05-15

  The present disclosure provides conjugate structures and compound structures used to produce these conjugates. Also provided are methods of producing drug-polypeptide or detectable label-polypeptide conjugates linked through a modified amino acid. Structures of the modified amino acids used in producing the conjugates are disclosed.

  本公开提供了用于制备这些共轭物的共轭结构和化合物结构。还提供了通过修饰的氨基酸连接的药物-多肽或可检测标记-多肽共轭物的制备方法。公开了用于制备共轭物的修饰氨基酸的结构。